Merck KGaA

Equities

MRK

DE0006599905

Pharmaceuticals

Real-time Estimate Tradegate 07:45:16 18/06/2024 pm IST 5-day change 1st Jan Change
168.6 EUR -1.56% Intraday chart for Merck KGaA -1.54% +17.38%

This article is for Premium subscribers only

Signed up already?

Log In

Not subscribed yet?

Subscribe

The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.

Economics Minister Habeck travels to China without prominent company representatives RE
German economy minister's China trip features low-key business delegation amid EV clash RE
Merck KGaA to Build EUR62 Million Facility for Life Science Business MT
Health Care Up as Defensive Rotation Continues - Health Care Roundup DJ
Merck KGaA Completes EUR180 Million German Distribution Center Expansion MT
Merck Opens Newly Expanded Life Science Distribution Center in Schnelldorf, Germany CI
High price target from HSBC drives Merck KGaA up DP
Global markets live: ASML, Intel, Microsoft, Tesla, J&J, Gitlab Our Logo
MERCK KGAA : JP Morgan remains its Buy rating ZD
MERCK KGAA : Barclays keeps its Buy rating ZD
Merck KGaA to Launch New Clinical Studies for Oncology Pipeline MT
Merck KGaA Provides Updates on the Oncology Pipeline and Focused Approach to the Research and Development of Potential New Medicines Designed to Improve the Futures of Cancer Treatment CI
Transcript : Merck KGaA - Special Call
MERCK KGAA : Buy rating from JP Morgan ZD
Merck KGaA: memorandum of understanding with South Korean institute CF
Merck KGaA Signs Korea Science Research Pact DJ
Merck KGaA Teams up With South Korean University to Support Life Sciences Research MT
MERCK KGAA : Jefferies reaffirms its Buy rating ZD
MERCK : A lower starting point for future growth Alphavalue
MERCK KGAA : Receives a Buy rating from UBS ZD
Merck KGaA: acquisition of U.S.-based Mirus Bio CF
Merck KGaA Buys Mirus Bio for $600 Million DJ
Merck to Buy Mirus Bio for $600 Million MT
MERCK KGAA : DZ Bank gives a Buy rating ZD
MERCK KGAA : Gets a Buy rating from Barclays ZD
Chart Merck KGaA
More charts
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
171.2 EUR
Average target price
186.1 EUR
Spread / Average Target
+8.65%
Consensus
  1. Stock Market
  2. Equities
  3. MRK Stock
  4. News Merck KGaA
  5. Merck KGaA : A European big pharma with positive momentum